Lv1
58 积分 2024-05-21 加入
Preclinical Development of GR2002 , a Novel Anti‐ TSLP Bispecific Antibody With Potent TSLP Inhibitory Effects
26天前
已完结
Dual-epitope targeting of TSLP to simultaneously block TSLPR and IL-7Rα with a Biparatopic nanobody
26天前
已完结
Lysosome-targeting chimeras evolve
1个月前
已完结
Artificial intelligence in antibody–drug conjugate development
2个月前
已完结
Generating Bispecific Human IgG1 and IgG2 Antibodies from Any Antibody Pair
2个月前
已完结
One‐Step Assembly of Homogeneous DAR4 ADCs via a Traceless Fc Ligand‐Directed Acylation Strategy
2个月前
已完结
Anti–PD-1 antibodies recognizing the membrane-proximal region are PD-1 agonists that can down-regulate inflammatory diseases
2个月前
已完结
Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch
4个月前
已完结
Rational design of a Nivolumab-based ANTI-PD-1 single chain variable fragment that blocks the interaction between PD-1 expressed on T-CELLS and PD-L1 ON CHO cells
4个月前
已完结
Bottom–Up Protein Analysis Workflow for Simultaneous Characterization of Payloads, Disulfide Bonds, and Free Thiols in Antibody–Drug Conjugates
4个月前
已完结
皖公网安备34019202002308
